sglt2 inhibitors vs glp 1 Renal outcomes of and GLP1 agonists in clinical practice Combining SGLT2 inhibitor and GLP-1

Bonifcio VD, Pereira SA, Serpa J, Vincent JB (2021) Cysteine metabolic circuitries: druggable targets in cancer

A physician-led experiment Steven Klein, an addiction medicine specialist at Caron, is leading a pilot program that represents one of the most extensive real-world tests of GLP-1 drugs for addiction to date

Others explore alternative peptide strategies for weight maintenance

The data is clear: drugs like Ozempic, Wegovy, and Zepbound represent one of the most significant medical breakthroughs of our generation

Eli Lilly and Co) is a first in class long-acting dual glucose-dependent insulinotropic polypeptide GIP/GLP-1 RA for the treatment of T2DM in adults

This outcome might be linked to the triggering of F-actin formation, as indicated by FITC-phalloidin staining